Compare MSA & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSA | GPCR |
|---|---|---|
| Founded | 1914 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 6.5B |
| IPO Year | N/A | 2023 |
| Metric | MSA | GPCR |
|---|---|---|
| Price | $177.71 | $88.85 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $185.25 | $103.09 |
| AVG Volume (30 Days) | 220.6K | ★ 1.2M |
| Earning Date | 02-13-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 3.07 | N/A |
| EPS | ★ 7.10 | N/A |
| Revenue | ★ $1,863,597,000.00 | N/A |
| Revenue This Year | $4.58 | N/A |
| Revenue Next Year | $5.61 | N/A |
| P/E Ratio | $25.37 | ★ N/A |
| Revenue Growth | ★ 3.31 | N/A |
| 52 Week Low | $127.86 | $13.22 |
| 52 Week High | $185.54 | $94.90 |
| Indicator | MSA | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 70.86 |
| Support Level | $176.10 | $87.00 |
| Resistance Level | $185.54 | $94.77 |
| Average True Range (ATR) | 3.58 | 5.08 |
| MACD | -0.18 | 0.09 |
| Stochastic Oscillator | 63.19 | 79.65 |
MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.